LONDON: ReNeuron Group plc, a pioneering UK-based biotechnology firm specializing in stem cell derived exosome technologies, has announced the board’s decision to appoint administrators. This move comes as a follow-up to the company’s previous announcement on 5 February 2024, which highlighted ongoing business development and financing discussions. Despite exhaustive efforts to explore various corporate…
LONDON: ReNeuron Group plc, a UK-based global leader in the development of cell-based therapeutics, has signed a new research evaluation agreement with a major US biotechnology company in connection with the use of the Company’s proprietary exosomes for the delivery of novel gene silencing therapeutics. This latest research collaboration will focus on the use…